PSCR (Proto Script Pharmaceutical) Beginning Cash Position: $0.00 Mil (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical Beginning Cash Position?

Proto Script Pharmaceutical PSCR Beginning Cash Position is $0.00 Mil as of Sep. 2017.

Proto Script Pharmaceutical's Beginning Cash Position for the quarter that ended in Sep. 2017 was $0.00 Mil.

Proto Script Pharmaceutical's quarterly Beginning Cash Position increased from Mar. 2017 ($0.00 Mil) to Jun. 2017 ($0.06 Mil) but then declined from Jun. 2017 ($0.06 Mil) to Sep. 2017 ($0.00 Mil).

Proto Script Pharmaceutical's annual Beginning Cash Position declined from May. 2014 ($0.05 Mil) to May. 2015 ($0.01 Mil) and declined from May. 2015 ($0.01 Mil) to May. 2016 ($0.00 Mil).

Proto Script Pharmaceutical Beginning Cash Position Related Terms

Proto Script Pharmaceutical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Beginning Cash Position Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Beginning Cash Position
0.00 0.00 0.05 0.01 0.00

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.01 0.00 0.06 0.00

Proto Script Pharmaceutical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.00 Mil mean?
Proto Script Pharmaceutical (PSCR) has a Beginning Cash Position of $0.00 Mil as of Sep. 2017. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Beginning Cash Position too high?
Proto Script Pharmaceutical's current Beginning Cash Position is $0.00 Mil.
How does Proto Script Pharmaceutical's Beginning Cash Position compare to EXCC and NXES?
Proto Script Pharmaceutical's Beginning Cash Position of $0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Business Services company?
A good Beginning Cash Position depends on the Business Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Proto Script Pharmaceutical and its competitors. Proto Script Pharmaceutical's current Beginning Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Beginning Cash Position of $0.00 Mil. The current Beginning Cash Position is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Beginning Cash Position is $0.00 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.